Epidemiological characteristics of women with high grade CIN who do and do not have human papillomavirus

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 3, 1999, Pages 252-257

  Tabrizi, Sepehr N ^a   Fairley, Christopher K ^b   Chen, Shujun ^a   Borg, Anthony J ^a   Baghurst, Peter ^c   Quit, Michael A ^a   Garland, Suzanne M ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; HLA DQ ANTIGEN; RETINOL; VIRUS DNA;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; PAPILLOMATOSIS; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUALITY; SOUTHERN BLOTTING; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; ALLELES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; DIET; DNA, VIRAL; FEMALE; HLA-DQ ANTIGENS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VICTORIA;

EID: 0032983995     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08239.x     Document Type: Article

References (23)

1. Schiffman MH, Bauer HM, Hoover RN et al. Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Nutl Cancer Inst 1993; 85: 958–964.
2. Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPVDNA. Lancet 1990; 335: 1171–1174.
3. Fairley CK, Chen S, Tabrizi SN, Quinn M. McNeil JJ, Garland SM. A novel method for the assessment of human papillomavirus infection. J Infecr Dis 1992; 165: 1103–1106.
4. Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Nut Cmcer Int 1992; 84: 394–398.
5. Toki T. Oikawa N, Tase T, Satoh S, Wada Y, Yajima A. Immunohistochemical demonstration of papillomavirus antigen in cervical dysplasia and vulvar condyloma. Gynecol Ubstrt Itrvrst 1986; 22: 97–101.
6. Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE, Burrell CJ. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 1991; 338: 910–913.
7. Baghurst KI, Record SJ. Computeriscd dietary analysis system for use with diet diaries or food frequency questionnaires. Cottrnr Health Sritd 1984; 8: 11–18.
8. Rohan TE, Potter JD. Retrospective assessment of dietary intake. Am J Epidemiol 1984; 120: 876–887.
9. Rohan TE, Record SJ, Cook MG. Repeatability of estimates of nutrient and energy intake: The quantitative food frequency approach. Nittr Rrs 1987; 7: 125–137.
10. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989: 7: 209–214.
11. Bauer HM, Ting Y. Greer CE et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265: 472–477.
12. Resnick RM, Cornelissen MT, Wright DK et al. Detection and typing of human papillomavirus in archival cervical cancer specimens hy DNA amplification with consensus primers. J Nrrrl Cuncer Insr 1990; 82: 1477–1484.
13. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503–517.
14. Lorincz AT, Lancaster WD, Temple GF. Cloning and characterization of the DNA of a new human papillomavirus from a women with dysplasia of the uterine cervix. J Virol 1986; 58: 225–229.
15. Tabrizi SN, Borg AJ, Garland SM. Reduction of vector contamination in detection of human papillomavirus DNA using full-length genomic DNAprobes. J Virol Meth 1991;32: 41–47.
16. Bugawan TL, Erlich HA. Rapid typing of HLA-DQBI DNA poly- morphism using non-radioactive oligonucleotide probes and ampli- fied DNA. Immunogen 1991; 33: 163–167.
17. Yang CS, Lee MJ. Methodology of plasma retinol. tocopherol and cartenoid assays in cancer prevention studies. J Nutr Growth Cancer 1987; 4: 19–27.
18. Jacobs MV, Husman AM, Brule AJC, Snijders PJF, Meijer CJ, Walboomers JMM. Group-specific differentiation between high and low risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995; 33: 901–905.
19. Burger MPM, Hollema H, Pieters WJLM, Schroder FP. Quint WGV. Epidemiological evidence of cervical intraepithelial neoplasia without the presence of human papillomavirus. Br J Cancer 1996; 73:831–836.
20. Brock KE, Berry G, Mock PA et al. Nutrients in diet and plasma and risk of in situ cervical cancer. J Natl Cancer Inst 1988; 80 580–585.
21. Tsang SS, Li G, Stich HF. Effect of retnoic acid on bovine papillomavirus (BPV) DNA-induced transformation and number of BPV-DNAcopies. Inr J Cancer 1988; 42: 94–98.
22. Wank R, Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 1991; 352: 723–725.
23. *0303. Lancet 1993: 341: 1215.